) , an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances such as 3,4-Methylenedioxymethamphetamine , natural GMP-grade psilocybin, along with natural health product formulations, is pleased to announce the receipt of its Natural Health Product Site Licence following an assessment by the Natural and Non-prescription Health Products Directorate.
Under section 29 of the Natural Health Products Regulations, the expanded licensing allows for the manufacturing, packaging, and labelling of Natural Health Products at the Company’s Princeton, British Columbia facility.“This expands our ability to produce our products on site for global market distribution,” said Optimi CEO, Bill Ciprick.
Today’s announcement affirms Optimi’s commitment to supplying large scale research and development programs through its 10,000 square foot GMP compliant manufacturing facility. Optimi Health Corp. an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances such as 3,4-Methylenedioxymethamphetamine , natural GMP-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: globeandmail - 🏆 5. / 92 Read more »
Source: VOCMNEWS - 🏆 74. / 51 Read more »